CSRIX
Price
$55.26
Change
-$0.40 (-0.72%)
Updated
Jul 31 closing price
Net Assets
8.99B
GRETX
Price
$9.44
Change
-$0.07 (-0.74%)
Updated
Jul 31 closing price
Net Assets
53.42M
Interact to see
Advertisement

CSRIX vs GRETX

CSRIX vs GRETX Comparison Chart in %
View a ticker or compare two or three
VS
CSRIX vs. GRETX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSRIX is a Hold and GRETX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSRIX has more cash in the bank: 8.99B vs. GRETX (53.4M). CSRIX pays higher dividends than GRETX: CSRIX (2.68) vs GRETX (1.66). CSRIX was incepted earlier than GRETX: CSRIX (26 years) vs GRETX (19 years). GRETX (1.45) is less costly to investors than CSRIX (0.76). CSRIX is a more actively managed with annual turnover of: 33.00 vs. GRETX (27.00). GRETX has a lower initial minimum investment than CSRIX: GRETX (0) vs CSRIX (1000000). CSRIX annual gain was more profitable for investors over the last year : 16.82 vs. GRETX (-14.51). CSRIX return over 5 years is better than : 17.56 vs. GRETX (-27.09).
CSRIXGRETXCSRIX / GRETX
Total Expense Ratio0.750.9678%
Annual Report Gross Expense Ratio0.761.4552%
Fund Existence26 years19 years-
Gain YTD17.09415.935107%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.99B53.4M16,828%
Annual Yield % from dividends2.681.66161%
Returns for 1 year16.82-14.51-116%
Returns for 3 years34.37-11.14-308%
Returns for 5 years17.56-27.09-65%
Returns for 10 years46.16-48.04-96%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DESRX29.060.10
+0.35%
DWS Enhanced Core Equity R
QQMNX23.080.07
+0.30%
Federated Hermes MDT Market Neutral IS
CEVYX13.46-0.03
-0.22%
Columbia Global Value Inst3
OMGCX22.46-0.11
-0.49%
JPMorgan Mid Cap Growth C
LOGSX25.50-0.29
-1.12%
Live Oak Health Sciences